Table 1.
Characteristic | Random cohort (n = 5,000) | Validation cohort (n = 19,884) | p-value |
---|---|---|---|
Patient | |||
Age, years | 65.4 ± 16.6 | 65.2 ± 16.5 | 0.45 |
Male gender | 55.3% | 54.3% | 0.18 |
Comorbidity (COPS2)a | 49 ± 48 | 49 ± 48 | 0.78 |
Hospitalization | |||
Admitted through EDb | 74.5% | 74.9% | 0.51 |
Most common diagnosis | Sepsis (20.0%) | Sepsis (20.1%) | – |
Need for surgery or procedure | 24.8% | 24.0% | 0.28 |
Severity of illness (LAPS2)c | 81.2 ± 51.5 | 82.4 ± 51.3 | 0.13 |
Code status | |||
Do not resuscitate | 6.8% | 7.4% | 0.11 |
Partial code | 1.9% | 1.9% | 0.88 |
Predicted hospital mortality | 6.7 ± 11.6% | 6.8 ± 11.2% | 0.91 |
Intensive care unit | |||
Severity of illness (eSAPS3)d | 9.6 ± 11.3% | 9.2 ± 11.3% | 0.07 |
Length of ICU stay, days | 2.7 ± 5.0 | 2.8 ± 5.6 | 0.55 |
Duration of ventilation, days | 0.9 ± 5.9 | 1.0 ± 4.4 | 0.77 |
Days receiving benzodiazepines | 0.2 ± 1.0 | 0.2 ± 0.9 | 0.95 |
Days receiving other sedatives | 0.5 ± 1.7 | 0.5 ± 1.6 | 0.20 |
Days receiving opiates | 0.3 ± 1.6 | 0.3 ± 1.5 | 0.74 |
Days receiving inotropes | 0.2 ± 0.9 | 0.2 ± 1.0 | 0.86 |
Days receiving vasopressors | 0.6 ± 2.1 | 0.6 ± 1.7 | 0.97 |
Any continuous vasopressor | 20.4% | 20.6% | 0.71 |
Discharge | |||
Total length of stay, days | 7.9 ± 11.7 | 8.3 ± 12.2 | 0.06 |
Hospital mortality | 11.2% | 10.2% | 0.04 |
Mortality at 30 days after hospital admission | 13.0% | 12.3% | 0.19 |
Discharge location | |||
Home | 72.1% | 71.2% | 0.19 |
Subacute nursing facility | 15.6% | 15.6% | 0.99 |
Hospice | 2.1% | 2.0% | 0.72 |
Readmission within 30 days | 19.6% | 18.7% | 0.18 |
Comorbidity Point Score, version 2
Emergency Department
Laboratory and Acute Physiology Score, version 2
Simplified Acute Physiology Score, version 2